Evidence map›Paper›PMID 32619303›Full record

ArticleGlia2020

FABP7 upregulation induces a neurotoxic phenotype in astrocytes.

Kelby M Killoy, Benjamin A Harlan, Mariana Pehar, Marcelo R Vargas

Open access · greenAbstract read
In one paragraph

Article in Glia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kelby M KilloyBiomedical Sciences Training Program, Medical University of South Carolina, Charleston, South Carolina, USA.
Benjamin A HarlanBiomedical Sciences Training Program, Medical University of South Carolina, Charleston, South Carolina, USA.
Mariana PeharDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Marcelo R VargasDepartment of Neurology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0003-1039-4210
Medical University of South Carolina · USUniversity of Wisconsin–Madison · US

Funding

Wisconsin Alzheimer's Disease Research CenterP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI AMY J. KIND · 2019 to 2026
$34.5M
NAD metabolsim and mitochondrial dysfunction in ALS modelsR01NS089640 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VARGAS, MARCELO R · 2015 to 2025
$3.4M
Circadian Timekeeping, Oxidative Stress and Metabolism in ALS ModelsR21NS102599 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VARGAS, MARCELO R · 2018 to 2019
$406k
NIA NIH HHS P30 AG062715NINDS NIH HHS R01 NS089640NINDS NIH HHS R21 NS102599
6 · The paper itself

Abstract

Fatty acid binding proteins (FABPs) are key regulators of lipid metabolism, energy homeostasis, and inflammation. They participate in fatty acid metabolism by regulating their uptake, transport, and availability of ligands to nuclear receptors. In the adult brain, FABP7 is especially abundant in astrocytes that are rich in cytoplasmic granules originated from damaged mitochondria. Mitochondrial dysfunction and oxidative stress have been implicated in the neurodegenerative process observed in amyotrophic lateral sclerosis (ALS), either as a primary cause or as a secondary component of the pathogenic process. Here we investigated the expression of FABP7 in animal models of human superoxide dismutase 1 (hSOD1)-linked ALS. In the spinal cord of symptomatic mutant hSOD1-expressing mice, FABP7 is upregulated in gray matter astrocytes. Using a coculture model, we examined the effect of increased FABP7 expression in astrocyte-motor neuron interaction. Our data show that FABP7 overexpression directly promotes an NF-κB-driven pro-inflammatory response in nontransgenic astrocytes that ultimately is detrimental for motor neuron survival. Addition of trophic factors, capable of supporting motor neuron survival in pure cultures, did not prevent motor neuron loss in cocultures with FABP7 overexpressing astrocytes. In addition, astrocyte cultures obtained from symptomatic hSOD1-expressing mice display upregulated FABP7 expression. Silencing endogenous FABP7 in these cultures decreases the expression of inflammatory markers and their toxicity toward cocultured motor neurons. Our results identify a key role of FABP7 in the regulation of the inflammatory response in astrocytes and identify FABP7 as a potential therapeutic target to prevent astrocyte-mediated motor neuron toxicity in ALS.

Indexed as

AstrocytesAmyotrophic Lateral SclerosisAnimalsFatty Acid-Binding Protein 7HumansMicePhenotypeSuperoxide DismutaseSuperoxide Dismutase-1Up-RegulationFabp7 protein, mouseFatty Acid-Binding Protein 7Superoxide DismutaseSuperoxide Dismutase-1amyotrophic lateral sclerosisastrocytesinflammationmotor neuronsNF-κB

Identifiers

PMID32619303
PMCPMC7573932
OpenAlexW3039792510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.